LAVAL, Quebec, March 3, 2016 /CNW/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today issued the following comments in response to inquiries from investors regarding Deb Jorn’s departure from Valeant.

It is our understanding that Deb Jorn decided to leave Valeant…